CHICAGO (Reuters) - A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of ...

The recalls of generic Zantac tainted by a suspected carcinogen continue to roll in. Two more companies have announced recalls of 18 lots of ranitidine heartburn meds in 150 mg and 300 mg doses.

The Food and Drug Administration is taking a drastic step over a common drug used to treat allergies and acid reflux, following an investigation that confirmed the persistent presence of a likely ...

A Delaware judge has dismissed a request from GSK Plc (NYSE:GSK) and other pharmaceutical companies to appeal a ruling that allows over 70,000 lawsuits alleging the heartburn drug Zantac causes cancer ...

(Reuters) -The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago. Jury selection began on Tuesday ...

Drugmaker Sanofi announced on Friday a voluntary recall of the heartburn drug Zantac from all stores in the United States and Canada amid investigations into the presence of a carcinogen discovered in ...

More generic versions of Zantac are being pulled from pharmacy shelves after officials discovered low levels of a probable carcinogen in the heartburn drug. The Food and Drug Administration this week ...

A Delaware Superior Court judge will hear litigation Monday from plaintiffs who say their cancer was caused by the popular heartburn medication Zantac. The judge will be tasked with determining ...

For the third time in the past week, a recall has been issued for the generic version of a popular heartburn and ulcer drug that is best known as Zantac. Amneal Pharmaceuticals on Tuesday voluntarily ...

Purchase generic zantac online prices There are no approved cytoxan cost uk animal drugs containing ranitidine. Archived from the original on 18 December After all, minimizing gastric acid helps ...

US health regulators are telling drugmakers to immediately pull their popular heartburn drugs off the market after determining that a contamination issue with the medications poses a greater risk than ...